Philips to nominate Feike Sijbesma and Peter Löscher as members of the Supervisory Board
2019年12月17日 - 4:00PM
Philips to nominate Feike Sijbesma and Peter Löscher as members of
the Supervisory Board
December 17, 2019
Amsterdam, the Netherlands – Royal Philips
(NYSE: PHG, AEX: PHIA), a global leader in health technology, today
announced that it will propose the appointments of Feike Sijbesma
and Peter Löscher as new members of the Supervisory Board to the
Annual General Meeting of Shareholders (AGM), which will be held on
April 30, 2020.
“We are pleased that Feike Sijbesma and Peter Löscher are
available to join Philips’ Supervisory Board,” said Jeroen van der
Veer, Chairman of the Supervisory Board of Royal Philips. “Mr.
Sijbesma is a recognized business and sustainability leader, while
Mr. Löscher is a seasoned business leader in the medical technology
and pharmaceutical industries. Their outstanding experience will be
highly valuable to Philips, as the company is expanding its
leadership in health technology solutions, on a mission to make the
world healthier and more sustainable through innovation.”
Subject to his appointment, Mr. Sijbesma will become
Vice-Chairman alongside the current Vice-Chairwoman Christine Poon,
whose third term will expire in 2021.
Additionally, Philips will propose the re-appointment of Ms.
Neelam Dhawan (Indian, 1959) for a period of two years as member of
the Supervisory Board in light of her in-depth knowledge of the IT
industry, including software engineering, research and IT services.
Subject to her re-appointment, Ms. Dhawan will retain her current
position within the Audit Committee.
Mr. Sijbesma (Dutch, 1959) currently is CEO and Chairman of the
Managing Board of Royal DSM. Under his leadership, DSM has gone
through a significant transformation and repositioned itself from a
chemical company into a life sciences & materials sciences
company. After 20 years on the DSM Managing Board and almost 13
years as its CEO, Mr. Sijbesma recently decided to step down as
DSM’s CEO and leave the company per May 1, 2020.
Mr. Löscher (Austrian, 1957) has held various executive
leadership positions in the medical technology and pharmaceutical
industries, including as President and CEO of Siemens AG, President
of Global Human Health and Member of the Executive Board of Merck
& Co., and CEO of GE Healthcare Bio-Sciences and member of GE’s
Corporate Executive Council.
For more information about Philips’ Supervisory Board, please
follow this link.
For further information, please
contact:
Ben ZwirsPhilips Global Press OfficeTel.: +31 6 15213446E-mail:
ben.zwirs@philips.com
Ksenija GonciarenkoPhilips Investor RelationsTel.: +31 20 59
77055E-mail: ksenija.gonciarenko@philips.com
About Royal PhilipsRoyal Philips (NYSE: PHG,
AEX: PHIA) is a leading health technology company focused on
improving people's health and enabling better outcomes across the
health continuum from healthy living and prevention, to diagnosis,
treatment and home care. Philips leverages advanced technology and
deep clinical and consumer insights to deliver integrated
solutions. Headquartered in the Netherlands, the company is a
leader in diagnostic imaging, image-guided therapy, patient
monitoring and health informatics, as well as in consumer health
and home care. Philips generated 2018 sales of EUR 18.1 billion and
employs approximately 80,000 employees with sales and services in
more than 100 countries. News about Philips can be found at
www.philips.com/newscenter.
- Feike Sijbesma
- Peter Loescher
Koninklijke Philips NV (EU:PHIA)
過去 株価チャート
から 3 2024 まで 4 2024
Koninklijke Philips NV (EU:PHIA)
過去 株価チャート
から 4 2023 まで 4 2024